When considering the defective DNA damage response and repair mechanisms observed in our present study, it is plausible to suggest that the higher incidence of cancer found in ADPKD patients compared to non-ADPKD patients could be attributed to compromised DNA repair mechanisms when patients have underlying germline PKD1 or PKD2 mutations. This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.